Performance Validation of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria in an Antiphospholipid Syndrome Cohort

CONCLUSIONS: The 2023 criteria offer higher overall specificity and improved sensitivity in specific patient subsets, such as those with SLE, microvascular manifestations, cardiac valve disease, and thrombocytopenia when compared to the 2006 criteria.PMID:38462219 | DOI:10.1016/j.jtha.2024.02.019

Source: Thrombosis and Haemostasis - March 10, 2024 Category: Hematology Authors: Yuan Zhao Can Huang Yangzhong Zhou Wanting Qi Bin Cai Chaojun Hu Yijun Song Tienan Zhu Xiaohua Shi Xinyan Liu Qian Wang Xinping Tian Yan Zhao Xiaofeng Zeng Mengtao Li Jiuliang Zhao Source Type: research